BCIRG 007: Serum HER2 levels in women with metastatic HER2-amplified breast cancer

被引：0
作者：
Sampson, E. L.
Valero, V.
Roche, H.
Pienkowski, T.
Canon, J.
Zhao, Y.
Carney, W.
Mackey, J.
Taupin, H.
Lindsay, M.
Buyse, M.
Slamon, D.
机构：
[1] Siemens Med Solut Diagnost, Tarrytown, NY USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Inst Claudius Regaud, Toulouse, France
[4] MS Curie Mem Canc Ctr, Warsaw, Poland
[5] CH Notre Dame, Charleroi, Belgium
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[8] CIRG, Paris, France
[9] CIRG, Edmonton, AB, Canada
[10] IDDI, Louvain, Belgium
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A109
引用
收藏
页码：A34 / A34
页数：1
相关论文
共 50 条
[21]   Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancer [J].
Yuan, Yuan ;
Lee, Jin Sun ;
Yost, Susan E. ;
Stiller, Tracey ;
Blanchard, M. Suzette ;
Padam, Simran ;
Katheria, Vani ;
Kim, Heeyoung ;
Sun, Canlan ;
Tang, Aileen ;
Martinez, Norma ;
Patel, Niki Dipesh ;
Sedrak, Mina S. ;
Waisman, James ;
Li, Daneng ;
Sanani, Shamel ;
Presant, Cary A. ;
Mortimer, Joanne .
JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (05) :752-758
[22]   Neratinib has clinical activity in HER2-amplified breast cancer patients with tumors that have acquired activating mutations in HER2 [J].
Cocco, Emiliano ;
Carmona, F. Javier ;
Won, Helen H. ;
Berger, Michael F. ;
Hyman, David M. ;
Rossi, Valentina ;
Chan, Carmen ;
Moriarty, Alyssa ;
Papadopoulos, Kyriakos P. ;
Wick, Michael J. ;
Cownie, James ;
Sarotto, Ivana ;
Cutler, Richard E. ;
Avogadri-Connors, Francesca ;
Savas, Peter ;
Lalani, Alshad S. ;
Boni, Valentina ;
Loi, Sherene ;
Baselga, Jose ;
Montemurro, Filippo ;
Scaltriti, Maurizio .
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
[23]   Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer [J].
Verschoor, Noortje ;
Smid, Marcel ;
Jager, Agnes ;
Sleijfer, Stefan ;
Wilting, Saskia M. ;
Martens, John W. M. .
BREAST CANCER RESEARCH, 2023, 25 (01)
[24]   Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer [J].
Noortje Verschoor ;
Marcel Smid ;
Agnes Jager ;
Stefan Sleijfer ;
Saskia M. Wilting ;
John W. M. Martens .
Breast Cancer Research, 25
[25]   The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer [J].
Boer R. .
Breast Cancer Research, 1 (1)
[26]   HER2-amplified gastric and colorectal cancers: Mechanistic insights into HER2 targeting approaches [J].
Leto, Simonetta Maria ;
Sassi, Francesco ;
Migliardi, Giorgia ;
Zanella, Eugenia ;
Catalano, Irene ;
Bertotti, Andrea ;
Trusolino, Livio .
CLINICAL CANCER RESEARCH, 2015, 21
[27]   Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells [J].
Fehm, Tania .
TUMOR BIOLOGY, 2007, 28 :22-22
[28]   Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer [J].
Vivien H. C. Bramwell ;
Gordon S. Doig ;
Alan B. Tuck ;
Sylvia M. Wilson ;
Katia S. Tonkin ;
Anna Tomiak ;
Francisco Perera ;
Theodore A. Vandenberg ;
Ann F. Chambers .
Breast Cancer Research and Treatment, 2009, 114
[29]   Anthracycline-free therapy for HER2-amplified breast cancer [J].
Gennari, Alessandra ;
Del Mastro, Lucia .
LANCET ONCOLOGY, 2013, 14 (11) :1037-1038
[30]   Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer [J].
Bramwell, Vivien H. C. ;
Doig, Gordon S. ;
Tuck, Alan B. ;
Wilson, Sylvia M. ;
Tonkin, Katia S. ;
Tomiak, Anna ;
Perera, Francisco ;
Vandenberg, Theodore A. ;
Chambers, Ann F. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) :503-511
12345